NEW YORK, Jan.
NEW YORK, Jan.
Urology Times is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the field of urology over the past 50 years. In this installment, Melissa R
Dr. Cato T. Laurencin, University Professor and Albert and Wilda Van Dusen Distinguished Endowed Professor of Orthopaedic Surgery, has developed synthetic artificial stem cells (SASC), a new class of stem cells that may avoid traditional pitfalls associated with stem cell therapies.
The global research report named Global Cell Therapy Bioprocessing Market from 2021 to 2027, recently distributed by MarketandResearch.biz, is a decent combination of excellent business understanding, intelligent arrangements, reasonable arrangements, and the latest innovation to offer a higher buyer experience. The worldwide Cell Therapy Bioprocessing market report covers a top-to-bottom assessment of status, development rate, most elevated parts of the market, and future technologies.
The eccentric billionaire who founded Amazon in 1994, is understood to be among a group of high-profile investors funding a rejuvenation startup in Northern California. The company Altos Labs was founded earlier this year by Russian billionaire Yuri Millner and is experimenting with so-called biological reprogramming technology. The tech, should it prove effective, could potentially extend the human lifespan by an impressive 50 years
TORONTO -- Clues to how psychiatric disorders like schizophrenia originate can be found in the early development of human brain cells, according to a new study that looked at human embryonic stem cells and gene expression data. While genetic risks have long been linked to psychiatric disorders, researchers have found new evidence that shows what part of the process disrupts brain cell development and their role in a wide range of psychiatric disorders.
Altos Labs, a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming, was launched on Jan 18(Tuesday). Altos said it will work on restoring cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life.
Generating a HACNS1 knock-in mouse model We designed a targeting construct for homologous recombination including a 1.2kb human sequence encompassing HACNS1 that was previously shown to encode human-specific enhancer activity in transgenic mouse embryos10. We replaced the orthologous mouse locus using homology-directed repair in C57BL6/J-AwJ/J (B6 agouti) embryonic stem (ES) cells (Fig.1B, Supplementary Figs.1A, B, Supplementary Data1; Methods).
In theglobal stem cells marketa sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share
Realizing the vision of culturing organs for use in life-saving transplantation procedures is still a long way off. However, the work of Prof. Jacob Hanna on stem cells is paving the way for this to become a reality.